• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
ACIP Updates: Recommendations for Use of 20-Valent Pneumococcal Conjugate Vaccine in Children - United States, 2023.美国免疫实践咨询委员会（ACIP）更新：2023年20价肺炎球菌结合疫苗在儿童中的使用建议
MMWR Morb Mortal Wkly Rep. 2023 Sep 29;72(39):1072. doi: 10.15585/mmwr.mm7239a5.
2
Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).免疫功能低下儿童（6-18 岁）中 13 价肺炎球菌结合疫苗和 23 价肺炎球菌多糖疫苗的使用：免疫实践咨询委员会（ACIP）的建议。
MMWR Morb Mortal Wkly Rep. 2013 Jun 28;62(25):521-4.
3
Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).预防婴幼儿肺炎球菌病-使用 13 价肺炎球菌结合疫苗和 23 价肺炎球菌多糖疫苗-免疫实践咨询委员会（ACIP）的建议。
MMWR Recomm Rep. 2010 Dec 10;59(RR-11):1-18.
4
Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP).《65 岁及以上成人中使用 13 价肺炎球菌结合疫苗和 23 价肺炎球菌多糖疫苗：免疫实践咨询委员会（ACIP）的建议》。
MMWR Morb Mortal Wkly Rep. 2014 Sep 19;63(37):822-5.
5
Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010.2010 年，免疫实践咨询委员会（ACIP）批准了 13 价肺炎球菌结合疫苗（PCV13）并提出了其在儿童中的使用建议。
MMWR Morb Mortal Wkly Rep. 2010 Mar 12;59(9):258-61.
6
Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).预防婴幼儿肺炎球菌疾病。免疫实践咨询委员会（ACIP）的建议。
MMWR Recomm Rep. 2000 Oct 6;49(RR-9):1-35.
7
Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP).PCV13 与 PPSV23 疫苗接种间隔：免疫实践咨询委员会（ACIP）的建议。
MMWR Morb Mortal Wkly Rep. 2015 Sep 4;64(34):944-7. doi: 10.15585/mmwr.mm6434a4.
8
Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007.13 价肺炎球菌结合疫苗获得许可前小儿侵袭性肺炎球菌病-美国，2007 年。
MMWR Morb Mortal Wkly Rep. 2010 Mar 12;59(9):253-7.
9
Licensure of 13-valent pneumococcal conjugate vaccine for adults aged 50 years and older.批准 13 价肺炎球菌结合疫苗用于 50 岁及以上成人。
MMWR Morb Mortal Wkly Rep. 2012 Jun 1;61(21):394-5.
10
Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).免疫功能低下成人患者使用 13 价肺炎球菌结合疫苗和 23 价肺炎球菌多糖疫苗：免疫接种实践咨询委员会（ACIP）的建议。
MMWR Morb Mortal Wkly Rep. 2012 Oct 12;61(40):816-9.

引用本文的文献

1
Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants.健康幼儿和婴儿同时接种肺炎球菌结合疫苗与常规儿科疫苗时的安全性和免疫原性。
Pediatr Infect Dis J. 2025 Aug 15;44(10):995-1008. doi: 10.1097/INF.0000000000004913.
2
Approaches to assess new pneumococcal vaccines for immunogenicity, development and licensure.评估新型肺炎球菌疫苗免疫原性、研发及获批的方法。
Hum Vaccin Immunother. 2025 Dec;21(1):2545032. doi: 10.1080/21645515.2025.2545032. Epub 2025 Aug 13.
3
Disparities in invasive pneumococcal disease, pneumonia, and otitis media among US children by comorbidity profile and insurance status.美国儿童侵袭性肺炎球菌疾病、肺炎和中耳炎在合并症情况及保险状况方面的差异。
Front Public Health. 2025 Jul 18;13:1558157. doi: 10.3389/fpubh.2025.1558157. eCollection 2025.
4
The epidemiology of bacterial meningitis in the United States during 2008-2023: an analysis of active, laboratory, population-based, multistate surveillance data.2008 - 2023年美国细菌性脑膜炎的流行病学：基于人群的多州主动实验室监测数据分析
Lancet Reg Health Am. 2025 May 12;47:101120. doi: 10.1016/j.lana.2025.101120. eCollection 2025 Jul.
5
A Phase 3 Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Vaccine, Compared with PPSV23, in Adults ≥50 Years of Age (STRIDE-10).一项3期随机试验，在≥50岁成人中比较成人专用肺炎球菌疫苗V116与23价肺炎球菌多糖疫苗（PPSV23）的安全性、耐受性和免疫原性（STRIDE-10）。
Vaccines (Basel). 2025 Mar 22;13(4):341. doi: 10.3390/vaccines13040341.
6
The microbiological characteristics and diagnosis of infection in the conjugate vaccine era.结合疫苗时代感染的微生物学特征与诊断
Hum Vaccin Immunother. 2025 Dec;21(1):2497611. doi: 10.1080/21645515.2025.2497611. Epub 2025 Apr 27.
7
Incidence Rates for Invasive and Infections in US Military Pediatric Dependents Before and During COVID-19.美国军事儿童家属在新冠疫情之前及期间侵袭性感染的发病率
Vaccines (Basel). 2025 Feb 24;13(3):225. doi: 10.3390/vaccines13030225.
8
Update on the evolving landscape of pneumococcal capsule types: new discoveries and way forward.肺炎球菌荚膜类型不断演变的格局最新进展：新发现与未来方向
Clin Microbiol Rev. 2025 Mar 13;38(1):e0017524. doi: 10.1128/cmr.00175-24. Epub 2025 Jan 29.
9
Health state utilities associated with invasive pneumococcal disease, pneumonia, and recurrent acute otitis media in young children.幼儿侵袭性肺炎球菌疾病、肺炎和复发性急性中耳炎相关的健康状态效用值。
Qual Life Res. 2025 Mar;34(3):809-821. doi: 10.1007/s11136-024-03840-8. Epub 2025 Jan 3.
10
PNEUMOCOCCAL SEROTYPE DISTRIBUTION AND COVERAGE OF EXISTING AND PIPELINE PNEUMOCOCCAL VACCINES.肺炎球菌血清型分布以及现有和在研肺炎球菌疫苗的覆盖情况
medRxiv. 2024 Dec 13:2024.12.12.24318944. doi: 10.1101/2024.12.12.24318944.

ACIP Updates: Recommendations for Use of 20-Valent Pneumococcal Conjugate Vaccine in Children - United States, 2023.

出版信息

MMWR Morb Mortal Wkly Rep. 2023 Sep 29;72(39):1072. doi: 10.15585/mmwr.mm7239a5.

DOI:10.15585/mmwr.mm7239a5
PMID:37768876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10545431/
Abstract
摘要